首頁 > 市場調查報告書 > 醫療設備

導管藥物遞輸設備

全球藥物洗脫球囊市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1421038

全球藥物洗脫球囊市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Drug Eluting Balloon Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球藥物洗脫球囊市場需求預計將從 2023 年的 654.03 萬美元達到 2032 年近 1332.69 萬美元的市場規模，2024 - 2032 年研究期間CAGR為 8.23%。

藥物洗脫球囊（DEB）是一種用於介入性心臟病學和血管外科的醫療器材。它旨在透過結合球囊血管成形術的優點和藥物輸送功能來治療狹窄或阻塞的動脈。該裝置由塗有抗再狹窄藥物（通常是抗增殖劑）的球囊組成。

市場動態

在多種因素的推動下，藥物洗脫球囊 (DEB) 市場正在經歷顯著成長。全球冠狀動脈疾病和周邊動脈疾病盛行率不斷上升是主要促進因素，從而產生了對微創治療的需求。 DEB 旨在預防球囊血管成形術後再狹窄，為解決動脈介入的常見問題提供了一種有針對性的方法。技術進步對於市場擴張至關重要，塗層技術、藥物配方和球囊設計的不斷創新提高了 DEB 的功效和安全性。 DEB 相對於其他治療方案（例如藥物洗脫支架）的偏好有助於其採用，提供藥物輸送而無需留下永久植入物的優勢。醫療保健專業人員越來越認知到藥物洗脫球囊 (DEB) 的優勢，加上良好的臨床結果，正在促進這些設備在動脈介入治療中的接受度不斷提高。監管部門的批准和有利的報銷政策也有助於提高 DEB 在臨床實踐中的可及性和採用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球藥物洗脫球囊市場的各個細分市場進行了包容性評估。藥物洗脫球囊產業的成長和趨勢為本研究提供了整體方法。

市場區隔

藥物洗脫球囊市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

冠冕
週邊
其他

依技術

帕科卡斯
自由太平洋
運輸公司
耐杜拉塗層
其他

按最終用戶

醫院及門診手術中心
導管實驗室
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物洗脫球囊市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物洗脫球囊市場的主要參與者包括拜耳公司、美敦力、B. Braun Melsungen AG、Cook Medical, Inc.、波士頓科學公司、Becton、Dickson and Company、EuroCor、Terumo Corporation、Koninklijke Philips NV。競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：藥物洗脫球囊公司的競爭格局

藥物洗脫球市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Bayer AG

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

B. Braun Melsungen AG

公司簡介
公司收入
產品
最近的發展

Cook Medical Inc.

公司簡介
公司收入
產品
最近的發展

Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Becton

公司簡介
公司收入
產品
最近的發展

Dickson and Company

公司簡介
公司收入
產品
最近的發展

EuroCor

公司簡介
公司收入
產品
最近的發展

Terumo Corporation

公司簡介
公司收入
產品
最近的發展

Koninklijke Philips NV

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113383

The global demand for Drug Eluting Balloon Market is presumed to reach the market size of nearly USD 1332.69 MN by 2032 from USD 654.03 MN in 2023 with a CAGR of 8.23% under the study period 2024 - 2032.

A drug eluting balloon (DEB) is a medical device used in interventional cardiology and vascular surgery. It is designed to treat narrowed or blocked arteries by combining the benefits of balloon angioplasty with drug-delivery capabilities. The device consists of a balloon coated with an anti-restenotic drug, typically an antiproliferative agent.

MARKET DYNAMICS

The Drug eluting balloon (DEB) market is witnessing a significant growth driven by various factors. The escalating prevalence of coronary artery disease and peripheral arterial disease globally is a primary driver, creating a demand for minimally invasive treatments. DEBs, designed to prevent restenosis after balloon angioplasty, offer a targeted approach to address a common issue in arterial interventions. Technological advancements are pivotal in market expansion, with ongoing innovations in coating technologies, drug formulations, and balloon designs enhancing the efficacy and safety of DEBs. The preference for DEBs over other treatment options, such as drug-eluting stents, contributes to their adoption, providing the advantage of drug delivery without leaving a permanent implant. The growing recognition among healthcare professionals regarding the advantages of Drug-Eluting Balloons (DEBs), coupled with favorable clinical outcomes, is fostering increased acceptance of these devices in arterial interventions. Regulatory approvals and favorable reimbursement policies also play a role enhancing the accessibility and adoption of DEBs in clinical practice.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug eluting balloon. The growth and trends of drug eluting balloon industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the drug eluting balloon market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Coronaty
Peripheral
Others

By Technology

Paccocath
Freepac
Transpax
Enduracoat
Others

By End-User

Hospitals And Ambulatory Surgery Centers
Cath Labs
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Eluting Balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Eluting Balloon market include Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DRUG ELUTING BALLOON - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Coronaty Historic and Forecast Sales by Regions
5.5 Peripheral Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Paccocath Historic and Forecast Sales by Regions
6.5 FreePac Historic and Forecast Sales by Regions
6.6 TransPax Historic and Forecast Sales by Regions
6.7 EnduraCoat Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals and Ambulatory Surgery Centers Historic and Forecast Sales by Regions
7.5 Cath Labs Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE DRUG ELUTING BALLOON COMPANIES

9.1. Drug Eluting Balloon Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF DRUG ELUTING BALLOON INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Bayer AG
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Medtronic
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. B. Braun Melsungen AG
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Cook Medical Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Boston Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Becton
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Dickson and Company
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. EuroCor
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Terumo Corporation
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Koninklijke Philips N.V.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments